Three Indiana University-led research innovations, designed to improve the treatment of Alzheimer’s disease and ovarian and other cancers, recently received patents from the U.S. Patent and Trademark Office. Below is information about each patent. Patent issued to small molecule inhibitors of ALDH for the treatment of epithelial ovarian cancer: The U.S. Patent and Trademark Office… Read more »
Tag: IU Melvin and Bren Simon Comprehensive Care Center
IU researcher developing new pediatric leukemia therapies
Pediatric leukemia affects approximately 4,000 children each year in the United States, and the incidence of the disease is steadily increasing year after year. Reuben Kapur, director of the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine, is working to discover new treatments that will improve patient care. He… Read more »
IU researcher’s drug to slow diabetic retinopathy successfully completes Phase 2 trial
Mark R. Kelley, the Betty and Earl Herr professor of pediatric oncology research at the Indiana University School of Medicine and associate director of basic science at the IU Melvin and Bren Simon Comprehensive Cancer Center, is celebrating the positive Phase 2 trial results of a first-of-its-kind drug he developed to slow the progression of… Read more »